SCHEMBL21026835

SCHEMBL21026835

Cc1ccc(-c2ccc3c(c2)oc2cccnc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 1/20 0.42
▸ MAOB P27338 6/20 0.40
▸ CLK1 P49759 1/20 0.37
▸ TNKS O95271 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ TNKS2 Q9H2K2 1/20 0.37
▸ PARP2 Q9UGN5 1/20 0.37
▸ L3MBTL1 Q9Y468 4/20 0.37
▸ NPC1 O15118 4/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ MAPK14 Q16539 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ ACHE P22303 1/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15695188 0.88 MEN1 (0.39) L3MBTL1NPC1MAPK14MEN1KMT2A
SCHEMBL16919861 0.87 ALDH1A1 (0.42) COMTMAOBL3MBTL1NPC1HSP90AA1
SCHEMBL21157144 0.82 CLK1 (0.39) CLK1L3MBTL1NPC1MAPK14MEN1
SCHEMBL21026833 0.79 KDM4E (0.43) COMTMAOBCLK1TNKSPARP1
SCHEMBL15696775 0.79 PRMT5 (0.41) NPC1MAPK14MEN1KMT2AATM
SCHEMBL17427794 0.78 MAOB (0.52) MAOBCLK1TNKSPARP1TNKS2
SCHEMBL21032312 0.78 CDK9 (0.39) COMTMAOBTNKSPARP1TNKS2
SCHEMBL13509561 0.78 NPC1 (0.41) L3MBTL1NPC1HSP90AA1MEN1KMT2A
SCHEMBL9917159 0.77 MAOB (0.58) MAOBTNKSPARP1TNKS2PARP2
SCHEMBL17523446 0.77 MAOB (0.58) MAOBTNKSPARP1TNKS2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512038-B2 Tetraphenylene triarylamine compounds Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-11-29 — — US disclosed
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS Beijing Summer Sprout Technology Co., Ltd. (CN) 2019-06-20 — — US disclosed
US-20190165278-A1 THIOPHENE-CONTAINING TRIARYLAMINE COMPOUNDS Beijing Summer Sprout Technology Co., Ltd. (CN) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512038-B2 Tetraphenylene triarylamine compounds OCIAD2, OCIAD1, SLC7A5 COMT 83/4885MAOB 123/4885CLK1 2690/4885
US-20190165278-A1 THIOPHENE-CONTAINING TRIARYLAMINE COMPOUNDS SLC18A1, SLC35E1, SLC18A2 COMT 58/4885MAOB 175/4885CLK1 3800/4885
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS OCIAD2, OCIAD1, SLC7A5 COMT 83/4885MAOB 123/4885CLK1 2690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback